Chiara Fuccio, Francesco Ceci, Elena Spinapolice, Paolo Montagna, Luca Alberizzi, Daniela D'Ambrosio, Paolo Castellucci, Stefano Fanti, Giuseppe Trifirò, Role of 18F-FDG PET/CT in the restaging of patients affected by clear cell renal carcinoma, «THE JOURNAL OF NUCLEAR MEDICINE», 2013, 54, pp. N/A - N/A [abstract]
Nanni C; Zompatori M; Ambrosini V; Montesi V; Mezzetti S; Ferretti A; Chondrogiannis S; Rubello D; Fanti S., The additional diagnostic value of contemporary evaluation of FDG PET/CT scan and contrast enhanced CT imaging both acquired by a last generation PET/CT system in oncologic patients., «BIOMÉDECINE & PHARMACOTHÉRAPIE», 2013, 67, pp. 172 - 178 [articolo]
Nanni C; Schiavina R; Rubello D; Ambrosini V; Brunocilla E; Martorana G; Fanti S, The detection of disease relapse after radical treatment for prostate cancer: is anti-3-18F-FACBC PET/CT a promising option?, «NUCLEAR MEDICINE COMMUNICATIONS», 2013, 34, pp. 831 - 833 [articolo]
Schiavina R;Ceci F;Borghesi M;BRUNOCILLA E.;Vagnoni V;Gacci M;Castellucci P;Nanni C;Martorana G;Fanti S, The dilemma of localizing disease relapse after radical treatment for prostate cancer: which is the value of the actual imaging techniques?, «CURRENT RADIOPHARMACEUTICALS», 2013, 6, pp. 92 - 95 [articolo]
Mamede M;Ceci F;Castellucci P;Schiavina R;Fuccio C;Nanni C;BRUNOCILLA E.;Fantini L;Costa S;Ferretti A;Colletti PM;Rubello D;Fanti S., The role of 11C-choline PET imaging in the early detection of recurrence in surgically treated prostate cancer patients with very low PSA level <0.5 ng/mL., «CLINICAL NUCLEAR MEDICINE», 2013, 38, pp. 342 - 345 [articolo]
Nanni C; Zamagni E; Celli M; Caroli P; Ambrosini V; Tacchetti P; Brioli A; Zannetti B; Pezzi A; Pantani L; Perrone G; Zompatori M; Cavo M; Colletti PM; Rubello D; Fanti S., The Value of 18F-FDG PET/CT after Autologous Stem Cell Transplantation (ASCT) in Patients Affected by Multiple Myeloma (MM): Experience With 77 Patients, «CLINICAL NUCLEAR MEDICINE», 2013, 38, pp. e74 - e79 [articolo]
Lucconi G.; Cicoria G.; Pancaldi D.; Lodi F.; Malizia C.; Fanti S.; Boschi S.; Marengo M., Use of 65Zn as a tracer for the assessment of purification in the 68Ga-DOTANOC synthesis., «APPLIED RADIATION AND ISOTOPES», 2013, 80, pp. 27 - 31 [articolo]
Francesco Ceci, Paolo Castellucci, Riccardo Schiavina, Chiara Fuccio, Stefano Boschi, Daniele Romagnoli, Elena Tabacchi, Marcelo Mamede, Cristina Nanni, Stefano Fanti, 11C-Choline PET/CT in hormonal resistant patients after radical prostatectomy, in: Supplement, «THE JOURNAL OF NUCLEAR MEDICINE», 2013, 53, pp. N/A - N/A (atti di: SNMMI Annual Meeting, St. Louis, MI, USA, 14 Giugno 2013) [atti di convegno-abstract]
Ceci F;Castellucci P;Mamede M;SCHIAVINA R.;Rubello D;Fuccio C;Ambrosini V;Boschi S;Martorana G;Fanti S, (11)C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomy., «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2013, 40, pp. 149 - 155 [articolo]
Ceci F; Schiavina R; Castellucci P; Brunocilla E; Fuccio C; Colletti PM; Ferretti A; Chondrogiannis S; Rubello D; Romagnoli D; Malizia C; Martorana G; Fanti S., 11C-choline PET/CT scan in patients with prostate cancer treated with intermittent ADT: a sequential PET/CT study., «CLINICAL NUCLEAR MEDICINE», 2013, 38, pp. 279 - 282 [articolo]
Carmelo Quarta;Filippo Lodi;Roberta Mazza;Ferdinando Giannone;Laura Boschi;Cristina Nanni;Enzo Nisoli;Stefano Boschi;Renato Pasquali;Stefano Fanti;Patricia Iozzo;Uberto Pagotto, 11C-meta-hydroxyephedrine PET/CT imaging allows in vivo study of adaptive thermogenesis and white-to-brown fat conversion, «MOLECULAR METABOLISM», 2013, 2, pp. 153 - 160 [articolo]Open Access
R. Bonfiglioli;C. Nanni;J. J. Morigi;M. Graziosi;F. Trapani;M. Bartoletti;F. Tumietto;V. Ambrosini;A. Ferretti;D. Rubello;C. Rapezzi;P. L. Viale;S. Fanti, (18)F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis., «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2013, 40, pp. 1190 - 1196 [articolo]
Ambrosini V; Zompatori M; Fasano L; Nanni C; Nava S; Rubello D; Fanti S, 18F-FDG PET/CT for the Assessment of Disease Extension and Activity in Patients With Sarcoidosis: Results of a Preliminary Prospective Study, «CLINICAL NUCLEAR MEDICINE», 2013, 38, pp. 171 - 177 [articolo]
Zinzani P.L.; Tani M.; Pulsoni A.; De Renzo A.; Stefoni V.; Broccoli A.; Montini G.C.; Fina M.; Pellegrini C.; Gandolfi L.; Cavalieri E.; Torelli F.; Scopinaro F.; Argnani L.; Quirini F.; Derenzini E.; Rossi M.; Pileri S.; Fanti S.; Baccarani M., A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma., «ANNALS OF ONCOLOGY», 2012, 23, pp. 415 - 420 [articolo]
R. Tonelli; A. McIntyre; C. Camerin; Z.S. Walters; K. Di Leo; J. Selfe; S. Purgato; E. Missiaglia; A. Tortori; J. Renshaw; A. Astolfi; K.R. Taylor; S. Serravalle; R. Bishop; C. Nanni; L.J. Valentijn; A. Faccini; I. Leuschner; S. Formica; Jorge S Reis-Filho9; V. Ambrosini; K. Thway; M. Franzoni; B. Summersgill; R. Marchelli; P. Hrelia; G. Cantelli-Forti; S. Fanti; R. Corradini; A. Pession; J. Shipley, Antitumor Activity of Sustained N-Myc Reduction in Rhabdomyosarcomas and Transcriptional Block by Antigene Therapy, «CLINICAL CANCER RESEARCH», 2012, 18, pp. 796 - 807 [articolo]
